Edwards Lifesciences (EW) Reports In-Line Q3 EPS
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $88.99 +0.74%
EPS Growth %: +10.4%
Financial Fact:
Diluted (in shares): 218.1M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +10.4%
Financial Fact:
Diluted (in shares): 218.1M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Edwards Lifesciences (NYSE: EW) reported Q3 EPS of $0.59, in-line with the analyst estimate of $0.59. Revenue for the quarter came in at $1.48 billion versus the consensus estimate of $1.48 billion.
GUIDANCE:
Edwards Lifesciences sees Q4 2023 revenue of $1.45-1.53 billion, versus the consensus of $1.54 billion.
For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- AnaptysBio, Inc. (ANAB) Tops Q2 EPS by 524c
- Premarket movers: Quest, Labcorp hit by CMS cuts
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
